Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06206252

Can Medical Cannabis Affect Opioid Use?

Sponsor: Thomas Jefferson University

View on ClinicalTrials.gov

Summary

The goal of this observational study is to learn how medical cannabis (MC) affects pain and the use of opioid pain medications. Participants who have chronic pain and use prescribed opioid pain medication will opt-in to using MC or not for the 3-month study. Participants who are certified in Pennsylvania will purchase specific medical cannabis products at a reduced cost from a partnering medical cannabis dispensary monthly. All participants will complete baseline, daily, and monthly assessments to observe changes across groups.

Official title: The Effect of Medical Cannabis on Opioid Use for Individuals with Chronic Pain

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

110

Start Date

2023-09-07

Completion Date

2026-01

Last Updated

2025-02-14

Healthy Volunteers

No

Interventions

OTHER

Medical Cannabis

Participants will be restricted to specific medical cannabis products from Ethos Dispensary. They will be randomized to one medical cannabis formulation (tincture or vaporization) for the duration of the study. Each month for three months, they will purchase a different composition (predominantly THC, predominantly CBD, or balanced products) of their designated formulation. The order of compositions will be randomized and double-blinded, so participants and the research team will not know which compositions of medical cannabis they are using each month.

Locations (1)

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States